Chemotaxis by a macrophage cell line, RAW264, is specifically inhibited by the intracellular accumulation of 3-deazaadenosylhomocysteine (3-deaza-AdoHcy). Intracellular accumulation of 3-deaza-AdoHcy is the result of incubation of the cells with 3-deazaadenosine, a compound that can function both as a substrate and as an inhibitor of adenosylhomocysteine (AdoHcy) hydrolase. Accumulation of AdoHcy per se, brought about in chemotactic cell lines by incubation with either 3-deazaadenosine or with 3-deazaaristeromycin, does not affect chemotaxis. The specific role of 3-deazaadenosine as an inhibitor of macrophage cell line chemotaxis is supported by the following findings. Another macrophage cell line, RAW309CR, is resistant to the inhibition of chemotaxis by 3-deazaadenosine, and the resistance can be ascribed to the failure to accumulate 3-deaza-AdoHcy in this cell line. It is noteworthy that both RAW264 and RAW309CR accumulate similar amounts of AdoHcy after incubation with 3-deazaadenosine. The difference in the accumulation of 3-deaza-AdoHcy in RAW264 and RAW309CR is explained by the finding that sonicates of RAW264 rapidly form 3-deaza-AdoHcy but sonicates of RAW309CR do not. Both hydrolysis of AdoHcy and the inhibition of the hydrolysis of AdoHcy by 3-deazaadenosine are the same in sonicates of the two macrophage cell lines.
No takes yet. Share an insight, caveat, or question.
Aksamit et al. (1982) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: